List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 53 studies with search of: "Rabeprazole"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Double-Blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis
Condition: Refractory Reflux Esophagitis
Interventions: Drug: E3810;   Drug: E3810;   Drug: E3810
2 Recruiting Compare How Effective Standard Dose Proton Pump Inhibitor (PPI) and Low Dose Tricyclic Antidepressant and Double Dose PPI to Standard Dose PPI and Placebo
Condition: Gastroesophageal Reflux Disease
Interventions: Drug: Rabeprazole 20mg, placebo dinner and bedtime;   Drug: Rabeprazole 20 mg two times, Placebo at bedtime;   Drug: Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant
3 Recruiting Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection
Conditions: Early Gastric Adenocarcinoma;   Adenocarcinoma, Tubular
Interventions: Drug: rabeprazole;   Drug: placebo
4 Active, not recruiting Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: omeprazole sodium IV;   Drug: Rabeprazole
5 Recruiting A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients.
Conditions: Gastroesophageal Reflux Disease;   GERD
Interventions: Drug: rabeprazole;   Drug: rabeprazole
6 Completed E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Condition: Heartburn
Interventions: Drug: Rabeprazole sodium;   Drug: Placebo
7 Completed E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Condition: Heartburn
Interventions: Drug: Rabeprazole Sodium;   Drug: Placebo
8 Recruiting Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding
Condition: Nonvariceal Upper Gastrointestinal Bleeding
Interventions: Drug: Intravenous Omeprazole;   Drug: Oral Rabeprazole
9 Completed Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg
Condition: Healthy
Interventions: Drug: Rabeprazole Sodium Tablets 20 mg;   Drug: Aciphex® Tablets 20 mg
10 Completed Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg
Condition: Healthy
Interventions: Drug: Rabeprazole Sodium Delayed-Release Tablets 20 mg;   Drug: Aciphex® Tablets 20 mg
11 Completed Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg
Condition: Healthy
Interventions: Drug: Rabeprazole Sodium Delayed-Release Tablets 20 mg;   Drug: Aciphex® Delayed-Release Tablets 20 mg
12 Recruiting Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
13 Recruiting Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
14 Recruiting Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
15 Not yet recruiting A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD).
Condition: Gastroesophageal Reflux
Intervention: Drug: Rabeprazole sodium
16 Completed A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn
Condition: Gastroesophageal Reflux
Intervention: Drug: rabeprazole and pantoprazole
17 Completed Rabeprazole Protection of Aspirin Induced Gastric Damage.
Condition: Normal Subjects
Intervention: Drug: Rabeprazole
18 Active, not recruiting Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole ER;   Drug: Ranitidine
19 Active, not recruiting Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole ER;   Drug: Ranitidine
20 Completed Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.
Conditions: Gastroesophageal Reflux;   Heartburn
Intervention: Drug: rabeprazole

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services